Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Shell
SHEL
|
+$1.04B |
| 2 |
State Street SPDR Portfolio Long Term Treasury ETF
SPTL
|
+$896M |
| 3 |
BHP
BHP
|
+$620M |
| 4 |
Amazon
AMZN
|
+$608M |
| 5 |
NVIDIA
NVDA
|
+$555M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RDS.A
Royal Dutch Shell PLC ADS Class A
RDS.A
|
+$813M |
| 2 |
Walt Disney
DIS
|
+$667M |
| 3 |
Intel
INTC
|
+$658M |
| 4 |
UnitedHealth
UNH
|
+$649M |
| 5 |
Cisco
CSCO
|
+$646M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.43% |
| 2 | Healthcare | 10.84% |
| 3 | Financials | 9.96% |
| 4 | Consumer Discretionary | 9.46% |
| 5 | Communication Services | 7.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
576
First Trust Nasdaq-100 Select Equal Weight ETF
QQEW
$1.82B
| $865K | ﹤0.01% |
8,067
+2,627
| +48% | +$279K |
|
577
Ligand Pharmaceuticals
LGND
$5.88B
| $840K | ﹤0.01% |
11,976
+64
| +0.5% | +$4.64K |
|
578
KLA
KLAC
$259B
| $828K | ﹤0.01% |
22,610
+8,070
| +56% | +$302K |
|
579
Affiliated Managers Group
AMG
$9.76B
| $804K | ﹤0.01% |
5,706
+29
| +0.5% | +$4.17K |
|
580
SouthState Bank Corp
SSB
$10.5B
| $795K | ﹤0.01% |
9,738
-98
| -1% | -$8.45K |
|
581
Vanda Pharmaceuticals
VNDA
$302M
| $787K | ﹤0.01% |
69,588
+29,786
| +75% | +$392K |
|
582
Broadstone Net Lease
BNL
$4.02B
| $781K | ﹤0.01% |
35,858
| – | – |
|
583
Motorola Solutions
MSI
$77.4B
| $781K | ﹤0.01% |
3,224
+2,140
| +197% | +$497K |
|
584
Waste Management
WM
$91B
| $777K | ﹤0.01% |
4,901
-1,440
| -23% | -$218K |
|
585
Lexicon Pharmaceuticals
LXRX
$1.1B
| $770K | ﹤0.01% |
368,194
+197,424
| +116% | +$547K |
|
586
Linde
LIN
$226B
| $762K | ﹤0.01% |
2,385
+10
| +0.4% | +$3.09K |
|
|
FISV
587
Fiserv Inc
FISV
$27.9B
| $752K | ﹤0.01% |
+7,414
| New | +$750K |
|
588
Lennar Class B
LEN.B
$20.8B
| $747K | ﹤0.01% |
11,503
| – | – |
|
589
iShares MSCI EAFE ETF
EFA
$80.2B
| $742K | ﹤0.01% |
10,083
+1,952
| +24% | +$146K |
|
590
Travelers Companies
TRV
$80.2B
| $738K | ﹤0.01% |
4,038
-181
| -4% | -$31K |
|
591
EPAM Systems
EPAM
$5.09B
| $736K | ﹤0.01% |
2,481
-289
| -10% | -$113K |
|
592
Camden Property Trust
CPT
$11.1B
| $733K | ﹤0.01% |
4,409
| – | – |
|
593
Fortinet
FTNT
$117B
| $729K | ﹤0.01% |
10,670
-940
| -8% | -$58.4K |
|
594
Target
TGT
$68B
| $728K | ﹤0.01% |
3,431
-900
| -21% | -$195K |
|
595
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23B
| $719K | ﹤0.01% |
13,901
+3,135
| +29% | +$165K |
|
596
Bruker
BRKR
$8.14B
| $716K | ﹤0.01% |
11,129
-271
| -2% | -$18.5K |
|
597
Labcorp
LH
$25.9B
| $713K | ﹤0.01% |
3,149
-180
| -5% | -$42.3K |
|
598
First Trust Dow Jones Internet Index Fund ETF
FDN
$5.45B
| $705K | ﹤0.01% |
3,754
+324
| +9% | +$61.7K |
|
599
Schwab International Equity ETF
SCHF
$68.7B
| $704K | ﹤0.01% |
38,330
-15,730
| -29% | -$292K |
|
|
SPPI
600
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $703K | ﹤0.01% |
545,198
| – | – |
|
Similar funds
Ken Fisher's Q1 2022 Portfolio in Review
As of Q1 2022, Ken Fisher held 1,181 positions worth $169B, down 5.1% from $179B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Fisher deployed $5.41B of net new capital in Q1 2022, opening 114 new positions and adding to 450 existing holdings. Its largest new stake was Shell: 19,596,216 shares worth $1.08B.
By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 30% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Walt Disney, an estimated $667M trimmed.
- Ken Fisher's largest Q1 2022 buy was Shell: 19,596,216 shares worth $1.08B.
- Ken Fisher added most to State Street SPDR Portfolio Long Term Treasury ETF in Q1 2022, an estimated $896M increase.
- Ken Fisher's biggest Q1 2022 reduction was Walt Disney, cutting an estimated $667M.
- Ken Fisher fully exited Royal Dutch Shell PLC ADS Class A in Q1 2022, selling an estimated $813M.
- Ken Fisher's ten largest holdings make up 31% of its $169B portfolio in Q1 2022.
- Ken Fisher opened 114 new positions and closed 95 in Q1 2022.
- Ken Fisher's portfolio value fell 5.1% quarter-over-quarter to $169B.
Based on Fisher Asset Management's 13F filing for Q1 2022, filed 5 May 2022.